Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

The World Exosomes Market 2019-2024 - Ultracentrifugation is Expected to Hold Significant Market Share - ResearchAndMarkets.com

May 24, 2019

DUBLIN--(BUSINESS WIRE)--May 24, 2019--

The “Exosomes Market - Growth, Trends, and Forecast (2019 - 2024)” report has been added to ResearchAndMarkets.com’s offering.

The exosomes market is expected to register a CAGR of nearly 18% during the forecast period, 2019-2024.

Key Market Trends

Ultracentrifugation is Expected to Hold Significant Market Share in the Isolation Method Segment

Centrifugation is employed to analyze the hydrodynamic properties of polymeric materials, including biopolymers, such as nucleic acids and proteins. In isolation methods, ultracentrifugation-based exosomes isolation (in particular differential) is considered as the gold standard, which generates the exceptionally high centrifugal forces of up to 1,000,000 g, and is among the commonly used and reported techniques in exosomes isolation.

One of the potential advantages with this technique is reduced cost and contamination risks with separation reagents. It has a large sample capacity and yields large amounts of exosomes. Drawbacks include large time, non-scalable, chances of damaging vesicle, and low yield. Global companies, such as Thermo Fisher Scientific, offer a range of total exosomes isolation kits, which offer reagents for cell culture media, serum, plasma, urine, and other body fluids, such as cerebrospinal fluid, ascetic fluid, amniotic fluid, milk, and saliva, among others.

North America Dominates the Market and is Expected to do the Same in the Forecast Period

The North American region holds one of the largest shares in the exosomes market, owing to better healthcare infrastructure, effective government policies, a huge base of multinational companies, and high awareness among people about diagnostics and healthcare. A large number of government-funded research studies have been conducted, regarding the role of drugs using exosomes in several kinds of cancers, such as melanoma, breast cancer, lung cancer, and pancreatic cancer, among others.

Companies, like Merck and Exosome Diagnostic, have sponsored and collaborated with several universities, such as Yale University and Michigan State University, to conduct clinical trials in the United States. Furthermore, these ventures are very well supported by government funding. The studies were mostly conducted for neoplasm.

Competitive Landscape

The exosomes market is highly competitive and consists of a number of major players. Companies, like Danaher (Beckman Coulter Inc.), Diagenode Inc., Fujifilm Holdings Corporation, Hitachi Chemical Diagnostics Inc., Lonza, MBL International, Miltenyi Biotec, Novus Biologicals, Qiagen, Thermo Fisher Scientific Inc., among others, hold the substantial market share in the exosomes market.

Key Topics Covered:


1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study




4.1 Market Overview

4.2 Market Drivers

4.2.1 Rising Prevalence of Cancer

4.2.2 Technological Advancements in Exosomes Isolation and Analytical Procedures

4.2.3 Growth in Government Initiatives and Funding for Exosome Research

4.2.4 Increasing Advanced Applications of Exosomes

4.3 Market Restraints

4.3.1 Stringent Regulatory Requirement for Approval and Commercialization of Exosome Products

4.3.2 Technical Difficulties with the Implementation and Usage of Exosomes

4.3.3 Lack of Skilled Professionals

4.4 Porter’s Five Forces Analysis


5.1 Isolation Method

5.1.1 Ultracentrifugation

5.1.2 Immunocapture on Beads

5.1.3 Precipitation

5.1.4 Filtration

5.1.5 Other Isolation Methods

5.2 Downstream Analysis

5.2.1 Cell Surface Marker Analysis through Flow Cytometry

5.2.2 Protein Analysis by Blotting and ELISA

5.2.3 RNA Analysis by NGS and PCR

5.2.4 Other Downstream Analyses

5.3 Application

5.3.1 Diagnostics

5.3.2 Therapeutics

5.4 Geography

5.4.1 North America US Canada Mexico

5.4.2 Europe Germany UK France Italy Spain Rest of Europe

5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific

5.4.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa

5.4.5 South America Brazil Argentina Rest of South America


6.1 Company Profiles

6.1.1 Danaher (Beckman Coulter Inc.)

6.1.2 Diagenode Inc.

6.1.3 Fujifilm Holdings Corporation

6.1.4 Hitachi Chemical Diagnostics Inc.

6.1.5 Lonza

6.1.6 MBL International

6.1.7 Miltenyi Biotec

6.1.8 Novus Biologicals

6.1.9 Qiagen

6.1.10 Thermo Fisher Scientific Inc.


For more information about this report visit https://www.researchandmarkets.com/r/jiffho

View source version on businesswire.com:https://www.businesswire.com/news/home/20190524005202/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biomaterials



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 05/24/2019 09:57 AM/DISC: 05/24/2019 09:57 AM